Company Releases
-
2018.12.03
J&J Subsidiary Launches IDE Study for AF
The study will evaluate Biosense Webster’s Heliostar radiofrequency balloon ablation catheter for the treatment of symptomatic drug refractory recurrent paroxysmal (intermittent) atrial fibrillation.
Read More -
2018.11.13
Another Chance for Medtronic’s Renal Denervation Therapy
The Dublin-based company has received FDA approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system with patients on medication for high blood pressure.
Read More -
2018.09.12
Medtronic Is an Example of Why Diversity Matters
Medtronic has been ranked third on the 2018 Thomson Reuters Diversity and Inclusion Index, jumping ten spots from number 13, which it held in 2016 and 2017.
Read More -
2018.09.04
An Australian Startup’s Unique Approach to Imaging Lung Function
4Dx has developed an algorithm-based software that converts X-ray images into more detailed airflow studies.
Read More -
2018.08.16
Is IBM Really Making Progress with Watson in Healthcare?
IBM’s senior VP of cognitive solutions and IBM research defended the company’s progress on bringing the benefits of AI to healthcare after recent media reports cast a negative light on the technology.
Read More -
2018.06.25
Senseonics Wins Nod for Implantable Long-Term CGM
Senseonics Holdings said it has received a PMA for the Eversense Continous Glucose Monitoring (CGM) system. The Germantown, Md-based company said the system is the first and only CGM to feature an implantable glucose sensor and provide long-term continuous monitoring for up to three months.
Read More -
2018.06.07
Medtronic Recalls HeartWare VADs Again Due to an Electrical Problem
The Class I recall includes 204,017 HeartWare devices, but the likelihood of the problem causing a serious adverse event in a patient is very low.
Read More -
2018.04.03
dfsdgdsgsg
2017年1月19日，国家食品药品监督管理总局发布YY/T0287-2017 /ISO13485:2016《医疗器械 质量管理体系 用于法规的要求》标准，将于2017年5月1日起实施。
Read More -
2018.02.28
Dexcom Shows It Can Still Hang With Abbott
Dexcom beats Wall Street expectations in earnings despite mounting pressures from Abbott’s Freestyle Libre and shifting diabetes market.
Read More -
2018.02.20
Medtronic is Making the Most of Value-Based Care
Medical device companies of all sizes have embraced value-based healthcare in recent years, and one of the industry’s top companies is now beginning to see its value-based care programs pay off.
Read More
